AurumNews - The Aurum Institute

World TB Day 2024: Aurum Institute Ghana commits to ending TB in Ghana

The commitment of The Aurum Institute Ghana to combating tuberculosis (TB) remains resolute. In support of World TB Day 2024, Aurum Ghana proudly stood alongside Ghana Health Services to address the ...
Prof Violet Chihota provides insights in TPT in World TB Day 2024 seminar

In commemoration of World TB Day 2024, esteemed experts convened at a virtual World TB Day Buildup Seminar to address the ongoing challenges and advancements in tuberculosis (TB) prevention. Hosted by...
USAID-Funded ACCELERATE Initiative to Boost Tuberculosis Elimination Efforts in South Africa

In a landmark move towards ending tuberculosis (TB) in South Africa, the U.S. Agency for International Development (USAID) has awarded the Aurum Institute US $47 million (approx. R886 million) to impl...
World TB Day: Fundação Aurum participates in Costa do Sol Health Fair to end TB in Maputo

In celebration of global efforts towards ending TB tuberculosis (TB) on World Tuberculosis Day, Fundação Aurum, alongside the Maputo City Council hosted the Costa do Sol Av. Marginal Health Fair in ...
World Tuberculosis Day: discover a Horizon 2020 project that is contributing to making a change in the field of tuberculosis treatment

...
World TB Day 2024: focus on long-term effects

...
Revolutionising Pediatric TB Prevention: Insights from the Rifapentine Dispersible Formulation Webinar

In a monumental stride towards global tuberculosis (TB) prevention, a powerhouse collaboration of leading organisations recently convened a groundbreaking webinar on the dispersible formulation of rif...
Community Statement: Safeguarding Children against Tuberculosis Takes Center Stage with Introduction of Child-Friendly Formulation of Rifapentine for Short-Course Tuberculosis Preventive Treatment

As community and civil society leaders who have worked determinedly to prevent tuberculosis (TB) in our communities, we herald the introduction of the world’s first child-friendly formulation of rif...
Aurum Institute Parktown Hosts Inspiring Leadership Roadshow

The Aurum Institute Parktown recently marked the next stop in the Aurum Leadership Roadshow, underscoring Aurum leadership's dedication to the Aurum values of Excellence, Innovation, Integrity, Respe...
Bill Gates’ 5 predictions about AI that will change the world

...
Aurum's Commitment to Healthcare Access and Health Equity in Africa

Lagos, Nigeria, May 9, 2024 - The Aurum Institute participated in the 2024 Industry Engagement Forum, themed “Unlocking Healthcare Value Chains and Driving Investment through Partnerships: Accelerat...
IAVI’s Human Immunology Laboratory relocates samples to Africa, fulfilling capacity strengthening goal

...
Aurum Becomes New Home for Key Assets from IAVI's Human Immunology Laboratory

Johannesburg, South Africa - May 13, 2024 - The Aurum Institute is the new custodian of key assets from IAVI's Human Immunology Laboratory (HIL), highlighting the shared dedication of both organisat...
World TB Month: PanTB-HM site tour

Tuberculosis remains a formidable global health challenge, causing significant morbidity and mortality worldwide. Even after successful treatment, many patients experience lasting lung damage, comprom...
Mahikeng Leadership Roadshow: Putting People at the Centre

Our recent Leadership Roadshow in Mahikeng certainly set a high standard! On the 15th of May, the Health Systems team came together to share in Aurum’s strategic vision. The event featured engaging ...
Aurum conducts Training and QI tour in North West Province

The Aurum Institute's Training and Quality Improvement (QI) team is dedicated to enhancing engagement and performance across the North West Province, ensuring high-quality implementation of HIV/AIDS a...
Prof Setswe discusses NHI Bill

...
Gilead Announces 100% Efficacy in HIV Prevention for Cisgender Women with Lenacapavir in Aurum conducted trial

The Aurum Institute welcomes the announcement from Gilead on the provisional results of the Phase 3 PURPOSE 1 trial. The trial has demonstrated that Gilead's twice-yearly injectable HIV-1 capsid inhib...
Spark School Kempton Park Primary hosts University Day

...
Diversity is a source of strength, rather than a cause of division

...